Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 199

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Nanoparticle‐Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges

Open access
Babu, Anish, Templeton, Amanda K., Munshi, Anupama, Ramesh, Rajagopal · 2013 · Journal of Nanomaterials

Abstract

The last decade has witnessed enormous advances in the development and application of nanotechnology in cancer detection, diagnosis, and therapy culminating in the development of the nascent field of “cancer nanomedicine.” A nanoparticle as per the National Institutes of Health (NIH) guidelines is any material that is used in the formulation of a drug resulting in a final product smaller than 1 micron in size. Nanoparticle‐based therapeutic systems have gained immense popularity due to their ability to overcome biological barriers, effectively deliver hydrophobic therapies, and preferentially target disease sites. Currently, many formulations of nanocarriers are utilized including lipid‐based, polymeric and branched polymeric, metal‐based, magnetic, and mesoporous silica. Innovative strategies have been employed to exploit the multicomponent, three‐dimensional constructs imparting multifunctional capabilities. Engineering such designs allows simultaneous drug delivery of chemotherapeutics and anticancer gene therapies to site‐specific targets. In lung cancer, nanoparticle‐based therapeutics is paving the way in the diagnosis, imaging, screening, and treatment of primary and metastatic tumors. However, translating such advances from the bench to the bedside has been severely hampered by challenges encountered in the areas of pharmacology, toxicology, immunology, large‐scale manufacturing, and regulatory issues. This review summarizes current progress and challenges in nanoparticle‐based drug delivery systems, citing recent examples targeted at lung cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2013/863951

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 199

Metadata

Authors
Babu, A., Templeton, A. K., Munshi, A., & Ramesh, R.
Venue
Journal of Nanomaterials
Publisher
Wiley
Published
2013-01
Volume
2013
Issue
1
ISSN
  • 1687-4110 (ISSN-L)
  • 1687-4129
OpenAlex
W2125249798
Cited by
199
References
3
FWCI
4.67
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nanoparticle‐Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges. https://app.cochat.ai/papers/10.1155/2013/863951
The paper
Babu, A., Templeton, A. K., Munshi, A., & Ramesh, R. (2013). Nanoparticle‐Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges. Journal of Nanomaterials. https://doi.org/10.1155/2013/863951

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.